Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) announced that the company has filed an application for the manufacture and sales in Japan of hydromorphone hydrochloride oral formulation (extended-release and immediate-release formulations), a narcotic analgesic.